Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedJan 24, 2026
DataAggregated Company Financials
Companies117
  • 7D3.1%
  • 3M8.3%
  • 1Y-2.3%
  • YTD7.6%

The Personal Products industry is up 3.1% in the last week, with Kenvue up 3.5%. Despite this gain, the industry's performance has been flat over the past year. Earnings are forecast to grow by 34% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 24 Jan 2026US$97.6bUS$47.6bUS$350.1m22.8x278.8x2x
Mon, 22 Dec 2025US$90.9bUS$47.6bUS$351.6m22.8x258.5x1.9x
Wed, 19 Nov 2025US$80.6bUS$47.6bUS$558.6m21.7x144.3x1.7x
Fri, 17 Oct 2025US$91.0bUS$47.7bUS$307.8m19.1x295.5x1.9x
Sun, 14 Sep 2025US$94.1bUS$47.6bUS$304.1m21.2x309.3x2x
Tue, 12 Aug 2025US$98.8bUS$48.1bUS$562.3m20.1x175.8x2.1x
Thu, 10 Jul 2025US$98.5bUS$48.0bUS$109.5m18x899.6x2.1x
Sat, 07 Jun 2025US$93.8bUS$48.0bUS$127.3m17.2x737.3x2x
Mon, 05 May 2025US$91.3bUS$48.3bUS$374.3m21.2x244x1.9x
Wed, 02 Apr 2025US$91.7bUS$48.7bUS$556.6m24.8x164.7x1.9x
Fri, 28 Feb 2025US$95.6bUS$49.0bUS$328.5m26.4x290.9x2x
Sun, 26 Jan 2025US$98.5bUS$49.3bUS$1.5b25.5x66.8x2x
Tue, 24 Dec 2024US$98.4bUS$49.3bUS$1.5b27.4x66.7x2x
Thu, 21 Nov 2024US$98.2bUS$49.3bUS$1.5b27x67x2x
Sat, 19 Oct 2024US$103.4bUS$49.5bUS$1.6b26.7x64x2.1x
Mon, 16 Sep 2024US$107.3bUS$49.5bUS$1.6b21.6x65.5x2.2x
Wed, 14 Aug 2024US$104.3bUS$49.2bUS$1.9b23.5x55.5x2.1x
Fri, 12 Jul 2024US$108.2bUS$49.0bUS$2.4b21.4x44.7x2.2x
Sun, 09 Jun 2024US$113.5bUS$49.0bUS$2.4b22.6x46.8x2.3x
Tue, 07 May 2024US$118.8bUS$48.7bUS$2.7b23.9x44.2x2.4x
Thu, 04 Apr 2024US$127.3bUS$48.8bUS$2.5b25.8x50.2x2.6x
Sat, 02 Mar 2024US$129.9bUS$49.0bUS$2.5b30.4x52.8x2.6x
Mon, 29 Jan 2024US$125.3bUS$50.1bUS$2.6b27.1x49.1x2.5x
Wed, 27 Dec 2023US$128.8bUS$49.9bUS$2.6b24.7x48.9x2.6x
Fri, 24 Nov 2023US$111.5bUS$50.0bUS$2.6b21.9x43.1x2.2x
Sun, 22 Oct 2023US$115.9bUS$50.0bUS$3.3b22.9x35.4x2.3x
Tue, 19 Sep 2023US$132.0bUS$50.0bUS$3.3b21.8x40.2x2.6x
Thu, 17 Aug 2023US$136.3bUS$49.8bUS$3.0b20.7x44.7x2.7x
Sat, 15 Jul 2023US$150.3bUS$49.3bUS$3.1b22x47.9x3x
Mon, 12 Jun 2023US$143.6bUS$49.3bUS$3.1b22.2x45.8x2.9x
Wed, 10 May 2023US$104.2bUS$48.9bUS$3.4b19.3x31.1x2.1x
Fri, 07 Apr 2023US$118.9bUS$34.6bUS$1.6b18.4x75.3x3.4x
Sun, 05 Mar 2023US$124.0bUS$34.9bUS$1.4b18.2x85.8x3.6x
Tue, 31 Jan 2023US$127.3bUS$35.9bUS$2.1b19.9x61.6x3.5x
Price to Earnings Ratio

61.6x


Total Market Cap: US$127.3bTotal Earnings: US$2.1bTotal Revenue: US$35.9bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 163.8x202420252026
Current Industry PE
  • Investors are optimistic on the American Personal Products industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 274x which is higher than its 3-year average PE of 164x.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.0x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 45% per year over the last three years.
  • Meanwhile revenues for these companies have grown 9.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market-0.39%
Consumer Staples0.74%
Personal Products3.06%
Personal Products3.06%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
KVUE KenvueUS$17.803.5%
+US$1.1b		-14.3%PE23.8x
EL Estée Lauder CompaniesUS$117.692.3%
+US$951.4m		42.7%PS2.9x
BRBR BellRing BrandsUS$27.6615.7%
+US$444.1m		-63.6%PE15.2x
IPAR InterparfumsUS$98.769.8%
+US$283.1m		-29.9%PE19.2x
COTY CotyUS$3.3610.2%
+US$271.1m		-54.9%PS0.5x

Latest News

OLPX
US$1.56
Olaplex Holdings
7D
-4.9%
1Y
-4.3%

OLPX: Henkel Takeover Talks Will Reshape Risk Reward Profile

Narrative Update: Olaplex Holdings (OLPX) The updated analyst price target for Olaplex Holdings reflects a small shift in fair value to about $3.59. Analysts characterize this as balancing a lower discount rate with changes to long term revenue growth, profit margin expectations, and future P/E assumptions following recent price target moves at Barclays, Jefferies, and Morgan Stanley.
HLF
US$16.64
Herbalife
7D
-1.9%
1Y
158.0%

Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth

Jan 22
Herbalife Ltd. (NYSE:HLF) Shares Fly 27% But Investors Aren't Buying For Growth
IPAR
US$98.76
Interparfums
7D
9.8%
1Y
-29.9%
ELF
US$94.16
e.l.f. Beauty
7D
4.6%
1Y
-14.8%
BRBR
US$27.66
BellRing Brands
7D
15.7%
1Y
-63.6%

BRBR: Future Performance Will Hinge On Execution In A Tougher Competitive Category

Analysts have trimmed their price targets on BellRing Brands, with our fair value estimate moving from US$40 to about US$26. They are factoring in lower projected revenue growth, slightly softer profit margins, a higher discount rate, and a reduced future P/E multiple, alongside concerns about competitive pressures and category volumes highlighted in recent research.
LFVN
US$6.14
LifeVantage
7D
-3.2%
1Y
-74.7%

LFVN: Gut Study Advances And Guidance Confidence Will Support Future Upside Potential

Analysts have kept their price target for LifeVantage unchanged at $14.50, reflecting only minor tweaks to assumptions around discount rate, revenue growth, profit margin and future P/E, rather than a shift in their overall view of the stock. What's in the News LifeVantage reported new in vitro study results for its proprietary P84 formula, showing strong biological activity in cellular pathways tied to gut regulation, repair, and restoration across four gut cell types, with all 14 analyzed peptides and proteins moving in the intended direction in a controlled, third party study (Key Developments).
COTY
US$3.36
Coty
7D
10.2%
1Y
-54.9%
EPC
US$19.56
Edgewell Personal Care
7D
4.8%
1Y
-42.2%

EPC: Buybacks And 2026 Earnings Guidance Will Shape Balanced Return Outlook

Analysts kept their fair value estimate for Edgewell Personal Care steady at $19.00, citing a slightly lower discount rate, revised revenue growth assumptions of 0.82%, a modestly higher profit margin outlook of 9.77%, and a minor adjustment to the future P/E to 4.77x as key inputs behind the unchanged target. What's in the News Edgewell Personal Care announced a share repurchase program authorizing up to $100 million in buybacks of its common stock (Buyback Transaction Announcements).
EL
US$117.69
Estée Lauder Companies
7D
2.3%
1Y
42.7%

EL: Future Equity Overhang From Lockups Will Likely Pressure Shares

Analysts have raised their price target on Estée Lauder Companies to about US$74 from roughly US$65, citing updated assumptions that include a lower discount rate, higher projected revenue, a modestly higher profit margin and a slightly higher future P/E multiple. What's in the News Estée Lauder Companies and Jo Malone London launched the Jo Malone London Scent Advisor, an AI-powered digital tool that uses Google's Gemini and Vertex AI to recommend fragrances online through a conversational experience for US and UK customers on JoMalone.com (Product-Related Announcements).
NUS
US$11.06
Nu Skin Enterprises
7D
-4.2%
1Y
60.5%

Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Could Signal Some Risk

Jan 17
Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Could Signal Some Risk
KVUE
US$17.80
Kenvue
7D
3.5%
1Y
-14.3%

KVUE: Share Price Will Recover As Legal Overhangs Ease After Kimberly-Clark Deal

Narrative Update on Kenvue Analysts have kept their fair value estimate for Kenvue steady at $19.33 per share while making only slight adjustments to inputs like discount rate, revenue growth, profit margin and future P/E. This reflects mixed recent research that highlights cautious views around litigation and consumer headlines, alongside some optimism in Skin Health and Beauty and potential M&A interest.
UPXI
US$2.00
Upexi
7D
-13.4%
1Y
-53.3%
FTLF
US$15.75
FitLife Brands
7D
-0.5%
1Y
-0.5%

Some Confidence Is Lacking In FitLife Brands, Inc.'s (NASDAQ:FTLF) P/E

Dec 16
Some Confidence Is Lacking In FitLife Brands, Inc.'s (NASDAQ:FTLF) P/E
BHST
US$5.61
BioHarvest Sciences
7D
15.0%
1Y
3.3%
NAII
US$4.15
Natural Alternatives International
7D
-11.6%
1Y
-1.9%

Natural Alternatives International, Inc.'s (NASDAQ:NAII) Shares Bounce 35% But Its Business Still Trails The Industry

Nov 25
Natural Alternatives International, Inc.'s (NASDAQ:NAII) Shares Bounce 35% But Its Business Still Trails The Industry
UG
US$6.50
United-Guardian
7D
-3.6%
1Y
-40.4%

United-Guardian (NASDAQ:UG) Will Be Looking To Turn Around Its Returns

Nov 08
United-Guardian (NASDAQ:UG) Will Be Looking To Turn Around Its Returns